Signal infrastructure is excellent and the creative has proven winners — but budget mechanics are leaking money. The worst campaign holds 62% of spend, the best campaign is switched off, and every live ad set is stuck in the learning phase. Fixing the structure alone could roughly double lead volume at the current budget.
Weighted across four dimensions. Meta's own Opportunity Score reads 91/100 — but that only grades setup toggles; it is blind to the budget-allocation and learning-phase issues that are actually driving cost.
Across the full quarter the account spent $2,677 for 101 applications at a $26.50 blended CPA — actually more efficient than the trailing 30 days, because the last month caught the account at its fatigue low, just before the July restructure.
| Month | Spend | CTR | CPM | Frequency |
|---|---|---|---|---|
| Apr (12–30) | $592 | 1.63% | $6.52 | 2.74 |
| May | $674 | 1.45% | $3.81 | 3.48 |
| June | $1,016 | 1.28% | $3.90 | 3.13 |
| Jul (1–10) | $394 | 1.51% ↑ | $6.96 | 2.62 ↓ |
Spend scaled ~65% into June while CTR fell to its quarterly low (1.28%) and frequency ran 3.1–3.5 — above the healthy <3.0 ceiling. Textbook fatigue: the same creatives pushed harder onto the same people. July is recovering (CTR up, frequency down) because the restructure put fresh creative into rotation.
"New patient trial" averages a healthy $26.73 CPA across 90 days — but that hides a collapse. First 60 days: 46 leads at ~$16.50 CPA (the account's best). Last 30 days: 9 leads at $78.96 — a 4.8× jump. It didn't get bad, it got fatigued: frequency on this campaign hit 4.07, the highest in the account.
A single static image (image 01) drove 48 of 101 applications this
quarter — nearly half — at ~$18 CPA, and it is now paused, with nothing proven at that scale to
replace it. When the hero fatigued there was no successor, so CPA spiked and every live ad set is now back
in the learning phase. This is the account's real vulnerability.
What this changes: creative concentration now outranks budget allocation as the #1 risk. The fix is 2–3 new proven winners in rotation — not one hero scaled until it breaks — plus a 2–4 week refresh cadence before fatigue, not after.
The Aspire pixel's SubmitApplication event (your actual optimisation
event) scores an Event Match Quality of 9.3 / 10 with the Conversions API live and firing
server-side, hourly. Email, phone and click-ID (fbc) are all matched at 100%. This is a
genuine competitive advantage under Meta's 2026 delivery model and it is doing real work — no changes needed.
| Event | EMQ | Phone | Click ID (fbc) | Status | |
|---|---|---|---|---|---|
| SubmitApplication | 9.3 | 100% | 100% | 100% | Excellent |
| Form (lead) | 9.3 | 100% | 100% | 100% | Excellent |
| PageView | 6.1 | 0% | 0% | 47% | Fine (top-funnel) |
PageView EMQ is low only because top-of-funnel traffic has no logged-in identifiers — this is expected and does not affect optimisation.
62% of the budget went to the campaign paying 4× more per lead, while the best-performing campaign (lowest CPA and highest CTR) is switched off. At the efficient campaigns' ~$19 CPA, the same $1,145 buys roughly 58 applications instead of 31.
| Campaign | Spend | % of budget | Leads | CPA | CTR | Status |
|---|---|---|---|---|---|---|
| New patient trial | $710.62 | 62% | 9 | $78.96 | 1.14% | Active |
| Red Light Therapy | $317.07 | 28% | 16 | $19.82 | 1.58% | Active |
| Health, Fitness & Longevity | $117.44 | 10% | 6 | $19.57 | 2.53% | Paused |
Only two ad sets are actually delivering, and both are in_learning_phase. To exit
learning, an ad set needs ~50 conversions in 7 days. At $16/day and a ~$15 CPA that is ~1 lead/day —
it will never get there. Meta's own guidance is a daily budget of at least 5× your target CPA
(~$75–100 here); the account is running at a fifth of that, so delivery stays unstable and expensive.
3 campaigns → ~10 ad sets → 49 ads, most now paused. Budget is sliced far too thin for Meta's 2026 delivery engine, which rewards fewer, larger ad sets with broad targeting. The two remarketing ad sets returned just 3 leads on $216 combined — retargeting pools are too small for a clinic funnel; that spend belongs in broad prospecting.
Most spend sits in now-paused ad sets (the account is mid-restructure). Live delivery is just two ad sets, both still learning.
| Ad set | Campaign | Daily | Spend | Leads | CPA | Delivery |
|---|---|---|---|---|---|---|
| LLA 1% · 02-07 | Red Light | $16 | $133.22 | 9 | $14.80 | Learning |
| Interest 2 · 09-07 | New patient | $24 | $32.89 | 0 | — | Learning |
| open · 08-06 (Aspire coaching) | Health/Fit | $15 | $117.44 | 6 | $19.57 | Campaign off |
| Open · 04-02 (dup) | Red Light | $16 | $183.85 | 7 | $26.26 | Paused |
| open · 02-06 | New patient | $24 | $206.42 | 5 | $41.28 | Paused |
| remarketing · 25-06 | New patient | $24 | $156.64 | 3 | $52.21 | Paused |
| health & wellness · 19-06 | New patient | $24 | $138.63 | 1 | $138.63 | Paused |
| remarketing · 07-07 | New patient | $24 | $59.56 | 0 | — | Paused |
The same ~8 creatives (image 01/03, video 01,
Carousel – Variation 2) are duplicated across ad sets with generic variation names. Meta's
2026 retrieval engine clusters near-identical creatives and suppresses delivery — 100 minor
variations perform no better than 10 genuinely distinct concepts. The account needs new angles
(problem-led, social-proof, comparison), not more variations of the same image. Format diversity itself
is fine — image, video and carousel are all present.